The Mexican hormones market, excluding contraceptives and antibiotics, has shown volatility from 2013 to 2023, with values peaking at $809.23 million in 2014 and declining to $541.34 million in 2023. The market experienced several fluctuations, with a significant decrease in 2016. In recent years, the market contracted continuously, with a 1.61% year-on-year decline in 2023 and a five-year CAGR of -1.84%.
Future trends to watch for include:
- Potential regulatory changes impacting the pharmaceutical sector.
- Innovations in hormone therapies and their acceptance in the market.
- Economic factors and healthcare spending influencing market growth.
